EVOFEM BIOSCIENCE INC (EVFM)
EVFM moved a median of 0.00% 30 minutes after news, and -0.60% by the close. How EVFM actually reacts to news — the realized, point-in-time move the market made, measured across 111 labeled events over the last three years with zero look-ahead.
EVFM’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 24% | 107 |
| 30-min | 0.00% | 29% | 107 |
| 60-min | 0.00% | 33% | 111 |
| to close | -0.60% | 38% | 111 |
| Middle 50% of EVFM reactions | -4.44% to +0.36% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 111 |
Half of all EVOFEM BIOSCIENCE INC news events land between -4.44% and +0.36% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when EVFM moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to EVFM's baseline. Nothing else.
Recent EVFM events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K Evofem Biosciences, Inc. For: Oct 09 | SEC filing · Form 8-K | SEC EDGAR | +1.06% | +6.38% | |
| Evofem Biosciences Adds Additional Manufacturing Capacity for PHEXX® to Support Global Growth Strategy | Press release | Business Wire | +0.00% | +0.00% | |
| Form 8-K Evofem Biosciences, Inc. For: Sep 17 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 10-Q Evofem Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.00% | |
| Evofem Biosciences Celebrates Shipment of Its 500,000th Unit of PHEXX®, Representing Hormone-Free Protection from Unintended Pregnancy for 6 Million Acts of Sex | Press release | Business Wire | +0.00% | +8.39% | |
| Form 8-K Evofem Biosciences, Inc. For: Jul 20 | SEC filing · Form 8-K | SEC EDGAR | +5.60% | +1.78% | |
| Form 8-K Evofem Biosciences, Inc. For: Jul 08 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -3.61% | |
| Evofem Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | Business Wire | +0.00% | +0.00% | |
| Form 8-K Evofem Biosciences, Inc. For: May 18 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 10-Q Evofem Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Evofem Biosciences, Inc. For: Apr 24 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -8.00% | |
| Evofem Announces Exclusive Agreement for the Distribution and Commercialization of SOLOSEC in Sub-Saharan Africa | Press release | Business Wire | +3.61% | +1.21% | |
| Form 8-K Evofem Biosciences, Inc. For: Apr 10 | SEC filing · Form 8-K | SEC EDGAR | +2.00% | -1.33% | |
| Form 8-K Evofem Biosciences, Inc. For: Mar 13 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.18% | |
| Evofem Reports Fifth Consecutive Year of Net Sales Growth | Press release | Business Wire | +0.00% | +5.75% | |
| Form 10-K Evofem Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +5.75% | |
| Form 8-K Evofem Biosciences, Inc. For: Mar 11 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +5.75% | |
| Evofem CEO Saundra Pelletier Calls for a “Ground-Up Reset” of Women’s Health at Fierce JPM Week 2026 | Press release | Business Wire | -5.75% | -0.82% | |
| Evofem Expands “Say Vagina” Campaign With Launch of Say Vagina Store | Press release | Business Wire | +1.16% | +1.16% | |
| Form 8-K Evofem Biosciences, Inc. For: Jan 12 | SEC filing · Form 8-K | SEC EDGAR | -4.25% | -4.25% | |
| Form 8-K Evofem Biosciences, Inc. For: Nov 26 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.60% | |
| Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE | Press release | PR Newswire | +0.00% | +12.78% | |
| Form DEF 14A Evofem Biosciences, Inc. For: Oct 29 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -3.33% | |
| Form 8-K Evofem Biosciences, Inc. For: Oct 20 | SEC filing · Form 8-K | SEC EDGAR | -3.55% | -0.51% | |
| Form PRE 14A Evofem Biosciences, Inc. For: Oct 20 | SEC filing · Form PRE | SEC EDGAR | -3.55% | -0.51% | |
| Form 8-K Evofem Biosciences, Inc. For: Oct 13 | SEC filing · Form 8-K | SEC EDGAR | -3.00% | -1.50% | |
| Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates | Press release | PR Newswire | -8.89% | -0.74% | |
| Evofem Biosciences Honors World Contraception Day | Press release | PR Newswire | +0.00% | +0.00% | |
| Form DEFA14A Evofem Biosciences, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -0.70% | +0.14% | |
| Form DEFA14A Evofem Biosciences, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +2.04% | +6.12% | |
| Form DEFM14A Evofem Biosciences, Inc. | SEC filing · Form DEFM14A | SEC EDGAR | -12.50% | -5.77% | |
| Form 8-K Evofem Biosciences, Inc. For: Aug 22 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.56% | |
| Form PREM14A Evofem Biosciences, Inc. For: Aug 26 | SEC filing · Form PREM14A | SEC EDGAR | +0.00% | +2.56% | |
| Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update | Press release | PR Newswire | +0.00% | +4.30% | |
| Form 10-Q Evofem Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +4.30% | |
| Form 8-K Evofem Biosciences, Inc. For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +4.30% | |
| Form DEF 14C Evofem Biosciences, Inc. For: Aug 05 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -3.13% | |
| Form PREM14A Evofem Biosciences, Inc. For: Jul 24 | SEC filing · Form PREM14A | SEC EDGAR | +0.00% | +0.00% | |
| Form PRE 14C Evofem Biosciences, Inc. For: Jul 09 | SEC filing · Form PRE | SEC EDGAR | +0.00% | -8.00% | |
| Form 8-K Evofem Biosciences, Inc. For: Jun 26 | SEC filing · Form 8-K | SEC EDGAR | -1.96% | -1.96% | |
| Form D Evofem Biosciences, Inc. | SEC filing · Form D | SEC EDGAR | — | +0.00% | |
| Evofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug Store | Press release | PR Newswire | -6.12% | +1.84% | |
| Notable Data on Evofem's SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting | Press release | PR Newswire | -16.67% | -16.67% | |
| Form 8-K Evofem Biosciences, Inc. For: May 19 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +5.26% | |
| Evofem Signs SOLOSEC License Agreement for Middle East with Pharma 1 | Press release | PR Newswire | -3.72% | +0.00% | |
| Evofem Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | PR Newswire | +0.00% | +7.47% | |
| Form 10-Q Evofem Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +7.47% | |
| Form 8-K Evofem Biosciences, Inc. For: May 15 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +7.47% | |
| Form 8-K Evofem Biosciences, Inc. For: May 03 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form D Evofem Biosciences, Inc. | SEC filing · Form D | SEC EDGAR | -4.44% | -4.44% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the EVFM section they belong to.
Where else EVFM is measured.
EVFM earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PETLIFE PHARMS INC (PTLF) | 112 | 0.00% | 34% |
| Taro Pharmaceutical Industries Ltd. Ordinary Shares (TARO) | 112 | -0.05% | 43% |
| Synlogic, Inc. (SYBX) | 111 | +0.29% | 53% |
| Aptose Biosciences Inc (APS_TSE) | 110 | 0.00% | 23% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is EVOFEM BIOSCIENCE INC's median reaction calculated?
Every labeled EVFM news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 111 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 29% of EVFM's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does EVFM's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.